Epididymo-orchitis caused by enteric organisms in men > 35 years old: beyond fluoroquinolones

  • Laura Ryan
  • Padraig Daly
  • Ivor Cullen
  • Maeve Doyle
Review
  • 17 Downloads

Abstract

Epididymo-orchitis is a common urological condition in men of all ages, causing a unilateral or bilateral swelling of the epididymis and/or testis. It is frequently caused by sexually transmitted infections, Chlamydia trachomatis and Neisseria gonorrheae, as well as common enteric organisms implicated in urinary tract infections. Men over 35 years old may develop epididymo-orchitis associated with enteric organisms, often associated with functional bladder outlet problems such as benign prostatic hyperplasia or urethral stricture disease. Fluoroquinolones, especially ciprofloxacin, have long been the mainstay of treatment for these infections; however, rising resistance to ciprofloxacin in E. coli isolates in Europe and the USA means that there is an unprecedented necessity for alternative antimicrobials with adequate penetration into genital tissues (epididymis and testes) to allow appropriate and comprehensive treatment of epididymo-orchitis in this group of patients.

Notes

Compliance with ethical standards

Conflict of interest

The authors declare they have no conflicts of interest.

Research involving human participants and/or animals

Not applicable

Informed consent

Not applicable

References

  1. 1.
    Holmes KK, Berger RE, Alexander ER (1979) Acute epididymitis: etiology and therapy. Arch Androl 3:309–316CrossRefPubMedGoogle Scholar
  2. 2.
    Dale AW, Wilson JD, Forster GE, Daniels D, Brook MG (2001) Management of epididymo-orchitis in Genitourinary Medicine clinics in the United Kingdom’s North Thames Region 2000. Int J STD AIDS 12:342–345CrossRefPubMedGoogle Scholar
  3. 3.
    Pilatz A, Hossain H, Kaiser R, Mankertz A, Schüttler CG, Domann E, Schuppe HC, Chakraborty T, Weidner W, Wagenlehner F (2015) Acute epididymitis revisited: impact of molecular diagnostics on etiology and contemporary guideline recommendations. Eur Urol 68:428–435CrossRefPubMedGoogle Scholar
  4. 4.
    Weidner W, Scheifer HG, Garbe C (1987) Acute nongonococcal epididymitis. Aetiological and therapeutic aspects. Drugs 34(Suppl 1):111–117CrossRefPubMedGoogle Scholar
  5. 5.
    Nicholson A, Rait G, Murray-Thomas T, Hughes G, Mercer CH, Cassell J (2010) Management of epididymo-orchitis in primary care: results from a large UK primary care database. Br J Gen Pract 60:407–422CrossRefGoogle Scholar
  6. 6.
    Nickel JC, Teichman JM, Gregoire M, Clark J, Downey J (2005) Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis and epididymitis in outpatient urological practice: the Canadian PIE study. Urology 66:935–940CrossRefPubMedGoogle Scholar
  7. 7.
    Robinson AJ, Grant JB, Spencer RC, Potter C, Kinghorn GR (1990) Acute epididymitis: why patient and consort must be investigated. Br J Urol 66:642–645CrossRefPubMedGoogle Scholar
  8. 8.
    Krieger JN (1984) Epididymitis, orchitis and related conditions. Sex Transm Dis 11:173–181CrossRefPubMedGoogle Scholar
  9. 9.
    Gruger T, Nitiss JL, Maxwell A, Zechiedrich EL, Heisig P, Seeber S, Pommier Y, Strumberg D (2004) A mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase II. Antimicrob Agents Chemother 48:4495–4504CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Rice LB (2012) Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones. Mayo Clin Proc 87:198–208CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
  12. 12.
    Surveillance of antimicrobial resistance in Europe 2017. Available from: https://ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2017
  13. 13.
    Antibiotic Resistance Patient Safety Atlas- Data on Antibiotic-Resistant Healthcare Associated Infections. Available from: https://gis.cdc.gov/grasp/PSA/
  14. 14.
    Sutter R, Rüegg S, Tschudin-Sutter S (2015) Seizures as adverse events of antibiotic drugs: a systematic review. Neurology 85:1332–1341CrossRefPubMedGoogle Scholar
  15. 15.
    Douros A, Grabowski K, Stahlmann R (2015) Safety issues and drug-drug interactions with commonly used quinolones. Expert Opin Drug Metab Toxicol 11:25–39CrossRefPubMedGoogle Scholar
  16. 16.
    BASHH: Clinical Effectiveness group, British Association for Sexual Health and HIV. [Internet] 2010 United Kingdom national guideline for the management of epididymo-orchitis. Available from: http://www.bashh.org
  17. 17.
    IUSTI: International Union against Sexually Transmitted Infection. [Internet] 2012 European guideline on the management of epididymo-orchitis. Available from: http://www.iusti.org
  18. 18.
    CDC: Centers for Disease Control and Prevention. [Internet] Sexually Transmitted Diseases Treatment Guideline, 2010. Available from: http://www.cdc.gov.
  19. 19.
    Alberta Health. [Internet] Alberta Treatment Guidelines for Sexually Transmitted Infection in Adolescents and Adults 2012. Available from: http://www.health.alberta.ca
  20. 20.
    Medscape. [Internet] Epididymo-orchitis empiric therapy regimes. Available from: http://www.medscape.com
  21. 21.
    EUA: European Association of Urology. [Internet] Urological infections guidelines: acute infective epididymitis. Available from: http://www.uroweb.org
  22. 22.
    SAH: South Asutralian Health. [Internet] Epididymo-orchitis diagnosis and treatment. Available from: http://www.sahealth.sa.gov.au
  23. 23.
    NZSHS: The New Zealand Sexual Health Societc Inc. [Internet] Epididymo-orchitis. Available from: http://www.nzshs.org
  24. 24.
    Vieler E, Jantos C, Scmhidts HL, Weidner W, Schiefer HG (1993) Comparative efficacies of ofloxacin, cefotaxime, and doxycycline for treatment of experimental epididymitis due to Escherichia coli in rats. Antimicrob Agents Chemother 37:846–850CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Ludwig M, Janos CA, Wolf S, Bergmann M, Failing K, Schiefer HG, Weidner W (1997) Tissue penetration of sparfloxacin in a rat model of experimental Escherchia coli epididymitis. Infection 25:178–184CrossRefPubMedGoogle Scholar
  26. 26.
    Ludwig M, Johannes S, Bergmann M, Falling K, Schiefer HG, Weidner W (2002) Experimental Escherichia coli epididymitis in rats: a model to assess the outcome of antibiotic treatment. BJU Int 90:933–938CrossRefPubMedGoogle Scholar
  27. 27.
    See WA, Taylor TO, Mack LA, Tartaglione TA, Opheim KE, Berger RE (1990) Bacterial epididymitis in the rat: a model for assessing impact of acute inflammation on epididymal antibiotic penetration. J Urol 144:780–784CrossRefPubMedGoogle Scholar
  28. 28.
    Tartaglione TA, Taylor TO, Opheim KE, See WA, Berger RE (1991) Antimicrobial tissue penetration in a rat model of E. coli epididymitis. J Urol 146:1413–1417CrossRefPubMedGoogle Scholar
  29. 29.
    Geny F, Costa P, Bressolle F, Galtier M (1993) Ceftriaxone pharmacokinetics in elderly subjects and penetration into the epididymis. Biopharm Drug Dispos 14:161–169CrossRefPubMedGoogle Scholar
  30. 30.
    Klotz T, Braun M, Wildfeuer A, Engelmann U (1996) Penetration of ampicillin and sulbactam into human epididymis and testis. Infection 24:372–374CrossRefPubMedGoogle Scholar
  31. 31.
    Seppänen J (1980) The penetration of sulfadiazine, sulfamethoxazole and trimethoprim into the prostate gland, epididymis and testis in man. Ann Clin Res 25:47–51Google Scholar
  32. 32.
    Frossard M, Joukhader C, Erovic BM, Dittrich P, Mrass PE, Van Houte M, Burgmann H, Georgopoulos A, Müller M (2000) Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues. Antimicrob Agents Chemother 44:2728–2732CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Redfern TR, English PJ, Baumber CD, McGhie D (1984) The aetiology and management of acute epididymitis. Br J Surg 71:703–705CrossRefPubMedGoogle Scholar
  34. 34.
    Eickhoff JH, Frimodt-Moller N, Walter S, Fridmodt-Moller C (1999) A double blind, randomized, controlled multicenter study to compare the efficacy of ciprofloxacin with pivampicillin as oral therapy for epididymitis in men over 40 years of age. BJU Int 84:827–834CrossRefPubMedGoogle Scholar
  35. 35.
    Dan M, Gottesman T, Schwartz O, Tsivian A, Gophna U, Rokney A (2012) Sexually transmitted Escherichia coli urethritis and orchiepididymitis. Sex Transm Dis 39:16–17CrossRefPubMedGoogle Scholar
  36. 36.
    Arneill M, Hennessy DB, McKay D (2013) Colovesical fistula presenting with epididymitis. BMJ Case Rep 23:2013Google Scholar
  37. 37.
    Humphreys H, Speller DC (1989) Acute epididymo-orchitis caused by Pseudomonas aeruginosa and treated with ciprofloxacin. J Inf Secur 19:257–261Google Scholar
  38. 38.
    Singhal S, Wagh DD, Kashikar S, Lonkar Y (2011) A case of acute epididymo-orchitis due to Pseudomonas aeruginosa presenting as ARDS in an immunocompetent host. Asian Pac J Trop Biomed 1:83–84CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Al-Obeid K, Al Khalifan NN, Jamal W, Kehinde EO, Rotimi VO (2006) Epididymo-orchitis and testicular abscess caused by Salmonella enteritidis in immunocompromised patients in Kuwait. Med Princ Pract 15:305–308CrossRefPubMedGoogle Scholar
  40. 40.
    Young AZ, Neujahr D, Setok L (2011) Case report. Epididymo-orchitis and bacteremia caused by Plesiomonas shigelloides in an HIV-infected patient. AIDS Read 11:617–619Google Scholar
  41. 41.
    Kashiwagi B, Okugi H, Kato Y, Shibata Y, Yamanka H (2000) Acute epididymo-orhictis with abscess formation due to Pseudomonas aeruginosa: report of 3 cases. Hinyokika Kiyo 46:915–918PubMedGoogle Scholar
  42. 42.
    Ma N, Chan V (1988) Ciprofloxacin treatment of Salmonella hadar epididymo-orchitis. J Antimicrob Chemother 21:383–384CrossRefGoogle Scholar
  43. 43.
    Pannek J, Pannek-Rademacher S, Cachin-Jus M (2014) Organ-preserving treatment of an epididymal abscess in a patient with spinal cord injury. Spinal Cord 52(Suppl 1):S7–S8CrossRefPubMedGoogle Scholar
  44. 44.
    Kang TW, Lee KH, Piao CZ, Yun KJ, Joo HJ, Park KS, Choi YD, Juhng SW, Choi c. (2007) Three cases of xanthogranulomatous epididymitis caused by E. coli. J Inf Secur 54:69–73Google Scholar
  45. 45.
    Garthwaite MA, Johnson G, Llody S, Eardley I (2007) The implementation of European Association of Urology guidelines in the management of acute epididymo-orchitis. Ann R Coll Surg Engl 89:799–803CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Mouton JW, Theuretzbacher U, Criag WA, Tulkens PM, Derendorf H, Cars O (2008) Tissue concentrations: do we ever learn? JAC 61:235–237PubMedGoogle Scholar
  47. 47.
    Syue LS, Chen YH, Ko WC, Hseuh PR (2016) New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance. Int J Antimicrob Agents 47:250–258CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Clinical MicrobiologyUniversity Hospital WaterfordWaterfordIreland
  2. 2.Department of UrologyUniversity Hospital WaterfordWaterfordIreland

Personalised recommendations